HDL: moving forward after disappointing results with HDL-mimetic in CARAT study.

Media formats available:

Self-assessment on statin eligibility without prescription using a web app
Self-assessment on statin eligibility without prescription using a web app
ACC.24
Self-assessment on statin eligibility without prescription using a web app
- Steven Nissen, MD
Promising results for APOC3 ASO in familial chylomicronemia syndrome
Promising results for APOC3 ASO in familial chylomicronemia syndrome
ACC.24
Promising results for APOC3 ASO in familial chylomicronemia syndrome
- Erik Stroes, MD, PhD
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC.24
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
- Daniel Gaudet, MD, PhD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
ACC.24
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
- Brian Bergmark, MD

PACE-CME